三个皮匠报告
最新
报告分类 研搜
BETA
政策库
自研报告
new
入驻
搜索
您的当前位置：首页 > 行业数据 > 多纳非尼ZGDD3临床研究无进展生存期数据（ITT集）
图片属性
图片格式：PNG 图片大小：136KB 图片尺寸：1217*624
同报告图片
 / 4
多纳非尼ZGDD3临床研究无进展生存期数据（ITT集）_第1页
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
多纳非尼ZGDD3临床研究无进展生存期数据（ITT集）_第2页
多纳非尼ZGDD3临床研究无进展生存期数据（ITT集）_第3页
多纳非尼ZGDD3临床研究无进展生存期数据（ITT集）_第4页
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
多纳非尼ZGDD3临床研究无进展生存期数据（ITT集）_第5页
所属报告： 泽璟制药-688266-A股公司研究报告：三抗创新出海管线储备丰富-260625（43页）.pdf
打包全文图表

相关数据

最新数据
全行业研究报告分享下载平台
  • 0731-84720580
  • 商务合作：really158d
  • 友链申请 (QQ)：1737380874
关于我们
更多
关于我们
三个皮匠报告微信公众号
三个皮匠报告微信小程序
扫码咨询网站充值下载问题
友情链接：
营销自动化 亿欧智库 微播易 阿里妈妈
copyright@2008-2013 长沙景略智创信息技术有限公司版权所有        网站备案/许可证号：湘B2-20190120 | 工信部备案号：湘ICP备17000430号-2 | 公安备案号：湘公网安备43010402001071号
客服
商务合作
小程序
服务号
折叠